Projects per year
Search results
-
Active
R1300CNR: Future Medicines Institute
Scott, C. (PI), Bruce, I. (CoI), Burden, R. (CoI), Burrows, J. (CoI), Collins, B. (CoI), Harrison, T. (CoI), James, J. (CoI), Kennedy, R. (CoI), Lawler, M. (CoI), Longley, D. (CoI), Maguire, S. (CoI), Malinova, D. (CoI), Maule, A. (CoI), McCloskey, K. (CoI), McDade, S. (CoI), Salto-Tellez, M. (CoI), Savage, K. (CoI), Stitt, A. (CoI) & Williams, R. (CoI)
15/10/2024 → …
Project: Research
-
R1093CNR: Regulation of cell fate by a novel p53-inducible ligand-independent TRAIL-R2 complex
McDade, S. (PI) & Longley, D. (CoI)
11/08/2019 → …
Project: Research
-
R1049CNR: The cell death regulator FLIP: evaluation of novel inhibitors in colorectal cancer
Longley, D. (PI), Dunne, P. (CoI), Harrison, T. (CoI), Kerr, E. (CoI) & McDade, S. (CoI)
29/03/2019 → …
Project: Research
-
Finished
R1135CNR: Exploiting the cancer epigenome to develop a common cancer vaccine
McDade, S. (PI), Jafarnejad, S. M. (CoI) & Scott, C. (CoI)
10/01/2020 → 30/06/2022
Project: Research
-
R2421CNR: Impact of chemotherapy on anti-cancer immunity in molecular-stratified subgroups of colorectal cancer
Longley, D. (PI), Coleman, H. (CoI), Dunne, P. (CoI), Lawler, M. (CoI), McArt, D. (CoI) & McDade, S. (CoI)
03/07/2017 → 31/01/2023
Project: Research
-
R1605CNR: MRC P2D 2015 - Development and validation of TempO-Seq assays for Immuno-Oncology application in cancer research and diagnostics
McDade, S. (PI) & McArt, D. (CoI)
19/02/2016 → 30/11/2016
Project: Research
-
R1557CNR: MRC P2D 2015 - Integrative environment for data acceleration, analysis and biomarker discovery
McArt, D. (PI) & McDade, S. (CoI)
09/09/2015 → 30/11/2016
Project: Research
-
R2116CNR: MOVEMBER CENTRE OF EXCELLENCE
O'Sullivan, J. (PI), Jain, S. (CoI), Kennedy, R. (CoI), McDade, S. (CoI), Prise, K. (CoI), Salto-Tellez, M. (CoI) & Waugh, D. (CoI)
21/05/2014 → 30/06/2019
Project: Research